Cyclerion Therapeutics (CYCN) Non-Current Assets (2019 - 2025)
Cyclerion Therapeutics (CYCN) has 7 years of Non-Current Assets data on record, last reported at $5.4 million in Q3 2025.
- For Q3 2025, Non-Current Assets changed 0.0% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $21.4 million, changed 0.0%, while the annual FY2024 figure was $5.4 million, 0.0% changed from the prior year.
- Non-Current Assets reached $5.4 million in Q3 2025 per CYCN's latest filing, roughly flat from $5.4 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $55.5 million in Q1 2021 and bottomed at $2.7 million in Q2 2021.
- Average Non-Current Assets over 5 years is $7.1 million, with a median of $5.4 million recorded in 2023.
- Peak YoY movement for Non-Current Assets: plummeted 95.99% in 2021, then surged 79.29% in 2024.
- A 5-year view of Non-Current Assets shows it stood at $3.9 million in 2021, then fell by 15.88% to $3.3 million in 2022, then surged by 64.16% to $5.4 million in 2023, then changed by 0.0% to $5.4 million in 2024, then changed by 0.0% to $5.4 million in 2025.
- Per Business Quant database, its latest 3 readings for Non-Current Assets were $5.4 million in Q3 2025, $5.4 million in Q2 2025, and $5.4 million in Q1 2025.